These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6085377)

  • 1. Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
    Fagan TC; Sternleib C; Vlachakis N; Deedwania PC; Mehta JL
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1109-13. PubMed ID: 6085377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nitrendipine and hydralazine on plasma catecholamines in essential hypertension.
    Lopez LM; Mehta JL; Baz R; Aguila E
    Clin Pharmacol Ther; 1984 Oct; 36(4):444-50. PubMed ID: 6478732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
    Jain AK; McMahon FG; Ryan JR; Maronde R; Vlachakis N; Mroczek W
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1053-9. PubMed ID: 6085366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
    Fritschka E; Distler A; Gotzen R; Thiede HM; Philipp T
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1100-4. PubMed ID: 6085375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind randomized cross-over study of the efficacy and tolerability of nifedipine and nitrendipine in the treatment of mild to moderate hypertension.
    Heagerty AM; Swales JD
    Br J Clin Pharmacol; 1989 Apr; 27(4):411-6. PubMed ID: 2655687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with nitrendipine--a new calcium antagonist--in hypertension.
    Andrén L; Hansson L; Orö L; Ryman T
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S387-91. PubMed ID: 6184574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of nitrendipine as baseline antihypertensive therapy.
    Rüddel H; Schmieder R; Langewitz W; Neus J; Wagner O; von Eiff AW
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1049-52. PubMed ID: 6085365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.
    Schoenberger JA; Glasser SP; Ram CV; McMahon SG; Vanov SK; Leibowitz DA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1105-8. PubMed ID: 6085376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA; Drayer JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.
    de Divitiis O; Petitto M; Di Somma S; Galderisi M; Villari B; Santomauro M; Fazio S
    Arzneimittelforschung; 1985; 35(4):727-9. PubMed ID: 3160356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifedipine tablet vs. hydralazine in patients with persisting hypertension who receive combined diuretic and beta-blocker therapy.
    Myers MG; Leenen FH; Burns R; Frankel D
    Clin Pharmacol Ther; 1986 Apr; 39(4):409-13. PubMed ID: 2869849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrendipine in the treatment of mild to moderate hypertension.
    Moser M; Lunn J; Nash DT; Burris JF; Winer N; Simon G; Vlachakis ND
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1085-9. PubMed ID: 6085372
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with long-term nitrendipine treatment in essential hypertension.
    Tourkantonis A; Lasaridis A; Settas L
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1090-5. PubMed ID: 6085373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness of BAY e 5009-nitrendipine in the treatment of mild and moderate arterial hypertension.
    Esper RJ; Esper RC; Baglivo HP; Castro JM; Rohwedder RW; Menna J
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1096-9. PubMed ID: 6085374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial of felodipine and nifedipine in refractory hypertension.
    Aberg H; Lindsjö M; Mörlin B
    Drugs; 1985; 29 Suppl 2():117-23. PubMed ID: 3886357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once- and twice-daily nitrendipine in patients with hypertension and noninsulin-dependent diabetes.
    Fagan TC; Nelson EB; Lasseter KC; Crook J; Morledge J; Conrad KA
    Pharmacotherapy; 1986; 6(3):128-36. PubMed ID: 2942844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muzolimine and nitrendipine in the treatment of arterial hypertension.
    de Divitiis O; Di Somma S; Petitto M; Galderisi M; Iacono C; Fazio S
    Z Kardiol; 1985; 74 Suppl 2():60-5. PubMed ID: 3159163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Felodipine vs hydralazine: a controlled trial as third line therapy in hypertension. Cooperative Study Group.
    Br J Clin Pharmacol; 1986 Jun; 21(6):621-6. PubMed ID: 2874821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.